The new whole-body magnetic resonance imaging (MRI) platform reportedly offers enhanced image quality and increased patient comfort.
Offering an array of advanced technologies, a newly FDA-approved magnetic resonance imaging (MRI) system may provide radiologists benefits across a variety of clinical applications.
Esaote North America said the Magnifico Open MRI device features metal artifact reduction (MAR), which can facilitate postoperative imaging for patients with metal implants. The system reportedly has a low level of susceptibility for metal in comparison to traditional MRI platforms, according to the company.
When it comes to sports-related injuries, Esaote North America noted the Magnifico Open MRI also has a “True-Motion” feature that allows for real-time imaging of a joint, according to the manufacturer.
In terms of image quality, the company said the Magnifico Open MRI has a high signal-to-noise ratio (SNR) and signal homogeneity that facilitate high spatial resolution.
Emphasizing patient comfort, the open platform may ease anxiety for children and patients with claustrophobia. Esoate North American also noted the device has a transparent head coil and laser alignment that enhance patient comfort and positioning.
“The Magnifico™ Open MRI is designed for patient comfort,” said Stephen Gibbs, the manager of MRI sales and marketing for Esaote North America. “With an open-gantry design, it is ideal for imaging children, large and claustrophobic patients. The compact size is uniquely suited for hospitals, imaging centers, and in-office clinics.”
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.